inHEART, a medical imaging solution provider for cardiac interventions, has closed a round of €3.7 million led by Elaia. The funding will be used to accelerate commercial growth in Europe, and to enter the US market, and to continue product development.
The company’s cloud-based software transforms preoperative medical images into a highly-detailed 3D map of the patient’s heart. This map enables the cardiologist to better plan the procedure and also to assist in navigating instruments in the patient’s heart, substantially reducing procedure duration and failure rates.
Heart rhythm disorders are a major cause of morbidity in the world. Current treatment including drugs, implantable devices or catheter ablation procedures are sub-optimal: repeat procedures are needed in 40% of patients with ventricular arrhythmias due to recurrence.
inHEART has been used on more than 2,000 patients in 40 centres around the world. Its ambition is to become a worldwide leader in image-guided diagnosis, therapy planning and navigation software solutions for heart rhythm disorders.
“After more than ten years of multidisciplinary collaboration as only a few exist in the world between cardiologists, radiologists, engineers and researchers in computer science, we have a disruptive technology that answers a real clinical need,” added Prof. Hubert Cochet, radiologist and co-founder of inHEART.
inHEART is a spin-off from two French research institutes: IHU Liryc in Bordeaux, specialising in cardiac electrophysiology; and Inria in Sophia Antipolis, in computer science. The founding team includes , founded by Jean-Marc Peyrat, CEO, Pierre Jaïs, a cardiologist, Hubert Cochet, cardiac radiologist, and Maxime Sermesant, expert in AI and cardiac modeling.